Diaphragm weakness and proteomics (global and redox) modifications in heart failure with reduced ejection fraction in rats

https://doi.org/10.1016/j.yjmcc.2020.02.002Get rights and content

Highlights

  • HFrEF causes diaphragm weakness differentially in moderate and severe disease.

  • Ribosomal and glycolytic metabolism proteins decrease in abundance in severe HFrEF.

  • Heightened cysteine and methionine oxidation occurs in thin filament proteins in severe HFrEF.

Abstract

Inspiratory dysfunction occurs in patients with heart failure with reduced ejection fraction (HFrEF) in a manner that depends on disease severity and by mechanisms that are not fully understood. In the current study, we tested whether HFrEF effects on diaphragm (inspiratory muscle) depend on disease severity and examined putative mechanisms for diaphragm abnormalities via global and redox proteomics. We allocated male rats into Sham, moderate (mHFrEF), or severe HFrEF (sHFrEF) induced by myocardial infarction and examined the diaphragm muscle. Both mHFrEF and sHFrEF caused atrophy in type IIa and IIb/x fibers. Maximal and twitch specific forces (N/cm2) were decreased by 19 ± 10% and 28 ± 13%, respectively, in sHFrEF (p < .05), but not in mHFrEF. Global proteomics revealed upregulation of sarcomeric proteins and downregulation of ribosomal and glucose metabolism proteins in sHFrEF. Redox proteomics showed that sHFrEF increased reversibly oxidized cysteine in cytoskeletal and thin filament proteins and methionine in skeletal muscle α-actin (range 0.5 to 3.3-fold; p < .05). In conclusion, fiber atrophy plus contractile dysfunction caused diaphragm weakness in HFrEF. Decreased ribosomal proteins and heighted reversible oxidation of protein thiols are candidate mechanisms for atrophy or anabolic resistance as well as loss of specific force in sHFrEF.

Introduction

As the main inspiratory muscle, the diaphragm is essential in ventilatory and non-ventilatory behaviors [1]. Patients with heart failure who have reduced ejection fraction (HFrEF) show a decline in maximal inspiratory pressure, which is an indirect marker of diaphragm force/function [2,3]. Maximal inspiratory pressure is an independent predictor of prognosis in patients with HFrEF [4,5]. Patient data and direct measurement of diaphragm abnormalities in rodent models of HFrEF suggest that dysfunction of this respiratory muscle contributes to the pathophysiology of HFrEF [3]. In general, diaphragm dysfunction leads to impaired airway clearance and predisposition to pneumonia, inability to sustain ventilation and shallow breathing that limits gas exchange during physical activity, and reflex sympathetic activation, which vasoconstricts the periphery as well as exacerbates pathological cardiac remodeling [3,6]. These physiological changes worsen patient symptoms of dyspnea and discomfort, and can accelerate disease progression. Therefore, it is important to resolve the underlying mechanisms of diaphragm dysfunction and develop new therapies for patients with HFrEF.

Assuming a maximal voluntary effort and sufficient neuromuscular transmission, the decrease in maximal inspiratory pressure in patients is the result of diaphragm fiber atrophy and contractile dysfunction. In animal models of HFrEF, some studies support and others refute the existence of diaphragm atrophy or contractile dysfunction [[7], [8], [9], [10], [11], [12]]. The decline in maximal inspiratory pressure in patients depends on disease severity [3,13]. Thus, we have recently postulated that diaphragm atrophy or loss of force in animal models of HFrEF depends on disease severity [3].

The systemic factors leading to diaphragm atrophy and contractile dysfunction in HFrEF appear to involve neurohumoral and inflammatory signaling [3]. These signaling events culminate in accumulation of reactive oxygen species and an oxidized shift in the intracellular redox balance [14,15]. Knockout of oxidant-producing enzymes or systemic antioxidant interventions prevent diaphragm weakness in HFrEF [8,9,16], suggesting that oxidants alter abundance or function of proteins to cause loss of force. Oxidant-signaling activates proteolytic pathways and increases protein degradation [17]. One of the main mechanisms of oxidant-mediated cellular signaling is through reversible oxidation of cysteine residues or other thiol groups in proteins [18]. For instance, reversible cysteine oxidation of myofibrillar and calcium-handling proteins lowers skeletal muscle shortening and force [[19], [20], [21], [22]]. It is important to note, however, that the specific changes in protein abundance and thiol redox modifications of proteins associated with diaphragm abnormalities in HFrEF remain unknown.

The main goal of our study was to understand the physiological and molecular basis of diaphragm weakness in HFrEF. We tested the hypothesis that diaphragm atrophy and loss of force depend on severity of HFrEF. Overall, diaphragm abnormalities were more pronounced in severe HFrEF. Therefore, we performed global label free proteomics and differential cysteine labeling focused on diaphragm of rats with severe HFrEF and healthy controls to better understand the protein abundance and redox modifications associated with diaphragm weakness. Our general hypotheses were that severe HFrEF increased proteins of catabolic pathways, decreased abundance of myofibrillar proteins, and heightened reversibly oxidized proteins in the diaphragm. Our data partially supported our hypotheses and reveal novel candidate mechanisms of diaphragm atrophy and contractile dysfunction, which include decreased abundance of key components of anabolic pathways and increased reversibly oxidized thiol groups in thin-filament proteins.

Section snippets

Animals and surgical intervention

All procedures conformed to the guiding principles for use and care of laboratory animals of the American Physiological Society and were approved by the University of Florida Institutional Animal Care and Use Committee (IACUC 201607964). Adult male Sprague-Dawley rats (initially 8–10 weeks old) were used in the present study. Rats were housed at the University of Florida under 12 h:12 h light-dark cycle and had access to standard chow and water ad libitum. Rats were randomly assigned to undergo

Animals

The characteristics of Sham, mHFrEF, and sHFrEF rats used for measurements of diaphragm isometric function, fiber cross-sectional area, and proteomic analysis are shown in Table 1. Rats with mHFrEF and sHFrEF demonstrated reduced fractional shortening, which is a defining characteristic of HFrEF. As expected by design, infarcted area of the left ventricle and right ventricle hypertrophy were higher in sHFrEF compared to mHFrEF. Serum BNP, a biomarker of heart failure, was significantly elevated

Discussion

The main findings of our study were: 1) moderate and severe HFrEF caused diaphragm fiber atrophy; 2) maximal diaphragm specific force was diminished in severe HFrEF, but not moderate HFrEF; 3) severe HFrEF decreased abundance of proteins involved in ribosomal function and glucose and glycolytic metabolism; 4) redox proteomics in severe HFrEF showed heightened reversible cysteine oxidation of thin-filament proteins, filamin C, and SERCA1, and increased methionine oxidation in sarcomeric actin.

Summary and conclusions

Our study shows that diaphragm fiber atrophy occurs in moderate and severe HFrEF, and loss of diaphragm fiber force occurs in severe HFrEF. These factors are the most likely culprits in the progressive decline in inspiratory function in patients. Our global proteomic analysis revealed downregulation of ribosomal and glucose metabolism/glycolysis proteins that will contribute to fiber atrophy or anabolic resistance and further accelerate fatigue in severe HFrEF. The redox proteomics

Funding

This study was funded by National Institutes of Health (NIH) grants R01 HL130318-01 (L.F. Ferreira) and BREATHE T32 HL134621 (trainee: R.C. Kelley, principal investigator: Gordon S. Mitchell, University of Florida).

Disclosures

None.

Author contributions

Conception and design of the experiments: R.C.K., B.M., and L.F.F. Collection and analysis of data: R.C.K., B.M., B.B., G.A.W., R.V., and L.F.F. Interpretation of data: R.C.K., B.M., B.B., G.A.W., R.V., and L.F.F. Drafting the article: R.C.K., B.M., and L.F.F. Critical revision of article for intellectual content: R.C.K., B.M., B.B., G.A.W., R.V., and L.F.F. All authors read and approved the manuscript before submission. All persons designated as authors qualify for authorship, and all those

Acknowledgements

We would like to thank Philip Coblentz, Nikhil Patel, and Ravi Patel for technical assistance. A portion of this work was performed in the McKnight Brain Institute at the National High Magnetic Field Laboratory's AMRIS Facility, which is supported by National Science Foundation Cooperative Agreement No. DMR-1644779* and the State of Florida.

References (77)

  • R. Del Rio et al.

    Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function

    J. Am. Coll. Cardiol.

    (2013)
  • P. Aukrust et al.

    Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

    Am. J. Cardiol.

    (1999)
  • T. Tsutamoto et al.

    Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

    J. Am. Coll. Cardiol.

    (1998)
  • H.W. van Hees et al.

    Heart failure decreases passive tension generation of rat diaphragm fibers

    Int. J. Cardiol.

    (2010)
  • J.T. Stull et al.

    Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle

    Arch. Biochem. Biophys.

    (2011)
  • T.P. Walsh et al.

    Effect of the state of oxidation of cysteine 190 of tropomyosin on the assembly of the actin-tropomyosin complex

    Biochim. Biophys. Acta

    (1980)
  • I. Dalle-Donne et al.

    Methionine oxidation as a major cause of the functional impairment of oxidized actin

    Free Radic. Biol. Med.

    (2002)
  • E.M. Balog et al.

    Calmodulin oxidation and methionine to glutamine substitutions reveal methionine residues critical for functional interaction with ryanodine receptor-1

    J. Biol. Chem.

    (2003)
  • T. Tiago et al.

    Peroxynitrite induces F-actin depolymerization and blockade of myosin ATPase stimulation

    Biochem. Biophys. Res. Commun.

    (2006)
  • L.P. Cahalin et al.

    Inspiratory muscle training in heart disease and heart failure: a review of the literature with a focus on method of training and outcomes

    Expert. Rev. Cardiovasc. Ther.

    (2013)
  • R.C. Kelley et al.

    Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology

    Heart Fail. Rev.

    (2017)
  • F.J. Meyer et al.

    Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance

    Circulation

    (2001)
  • S.H.R. Ramalho et al.

    Inspiratory muscle strength and six-minute walking distance in heart failure: prognostic utility in a 10 years follow up cohort study

    PLoS One

    (2019)
  • N. Hamazaki et al.

    Respiratory muscle weakness increases dead-space ventilation ratio aggravating ventilation-perfusion mismatch during exercise in patients with chronic heart failure

    Respirology

    (2019)
  • H.W. van Hees et al.

    Diaphragm single-fiber weakness and loss of myosin in congestive heart failure rats

    Am. J. Physiol. Heart Circ. Physiol.

    (2007)
  • O. Laitano et al.

    Pharmacological targeting of mitochondrial reactive oxygen species counteracts diaphragm weakness in chronic heart failure

    J. Appl. Physiol.

    (2016)
  • B. Ahn et al.

    NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure

    Am. J. Phys. Lung Cell. Mol. Phys.

    (2015)
  • N. Mangner et al.

    Exercise training prevents diaphragm contractile dysfunction in heart failure

    Med. Sci. Sports Exerc.

    (2016)
  • G. Stassijns et al.

    Systolic ventricular dysfunction causes selective diaphragm atrophy in rats

    Am. J. Respir. Crit. Care Med.

    (1998)
  • T.E. Gillis et al.

    Dissecting the role of the myofilament in diaphragm dysfunction during the development of heart failure in mice

    Am. J. Physiol. Heart Circ. Physiol.

    (2016)
  • G.S. Supinski et al.

    Neutral sphingomyelinase 2 is required for cytokine-induced skeletal muscle calpain activation

    Am. J. Phys. Lung Cell. Mol. Phys.

    (2015)
  • G.S. Supinski et al.

    Diaphragmatic free radical generation increases in an animal model of heart failure

    J. Appl. Physiol.

    (2005)
  • M.B. Reid et al.

    Cytokines and oxidative signalling in skeletal muscle

    Acta Physiol. Scand.

    (2001)
  • H.J. Forman et al.

    Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers

    Am. J. Phys. Cell Phys.

    (2004)
  • T.L. Dutka et al.

    Modulation of contractile apparatus Ca2+ sensitivity and disruption of excitation-contraction coupling by S-nitrosoglutathione in rat muscle fibres

    J. Physiol.

    (2011)
  • F.H. Andrade et al.

    Contractile response of skeletal muscle to low peroxide concentrations: myofibrillar calcium sensitivity as a likely target for redox-modulation

    FASEB J.

    (2001)
  • G.S. Posterino et al.

    Effects of reducing agents and oxidants on excitation-contraction coupling in skeletal muscle fibres of rat and toad

    J. Physiol.

    (1996)
  • H.M. Empinado et al.

    Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content

    Eur. J. Heart Fail.

    (2014)
  • Cited by (0)

    View full text